+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 100 Pages
  • Africa
From
United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United States
From
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030 - Product Thumbnail Image

U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030

  • Report
  • December 2022
  • 196 Pages
  • United States
From
Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032

  • Report
  • December 2022
  • 223 Pages
  • Global
From
US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026 - Product Thumbnail Image

US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026

  • Report
  • January 2021
  • 600 Pages
  • United States
From
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026 - Product Thumbnail Image

Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026

  • Report
  • December 2021
  • 95 Pages
  • Global
From
Benign Prostatic Hyperplasia Treatment Market by Type (Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA)), End User (Hospitals) - Global Forecast to 2026 - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Market by Type (Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA)), End User (Hospitals) - Global Forecast to 2026

  • Report
  • February 2021
  • 154 Pages
  • Global
From
Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030

  • Report
  • October 2022
  • 80 Pages
  • Global
From
Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), by Region, and Segment Forecasts, 2020-2027 - Product Thumbnail Image

Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), by Region, and Segment Forecasts, 2020-2027

  • Report
  • November 2020
  • 90 Pages
  • Global
From
Global Prostate Cancer Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024) - Product Thumbnail Image

Global Prostate Cancer Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • Report
  • November 2020
  • 124 Pages
  • Global
From
Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis - Product Thumbnail Image

Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • Report
  • March 2023
  • 285 Pages
  • Global
From
Prostate Cancer Treatment Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End Users, and Geography - Product Thumbnail Image

Prostate Cancer Treatment Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End Users, and Geography

  • Report
  • March 2024
  • 150 Pages
From
Castrate Resistant Prostate Cancer Therapeutics Market - Growth, Trends And Forecasts (2022 - 2027) - Product Thumbnail Image

Castrate Resistant Prostate Cancer Therapeutics Market - Growth, Trends And Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 112 Pages
  • Global
From
Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
Benign Prostatic Hyperplasia Market - Growth, Trends, and Forecasts (2020-2025) - Product Thumbnail Image

Benign Prostatic Hyperplasia Market - Growth, Trends, and Forecasts (2020-2025)

  • Report
  • May 2020
  • 114 Pages
  • Global
From
Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022 - Product Thumbnail Image

Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022

  • Report
  • May 2019
  • 319 Pages
  • United States, Europe United States, Europe
From
Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027 - Product Thumbnail Image

Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 160 Pages
  • Global
From
Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more